Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 705 (USA) (Dr. Muller)
· consented 2013-03-10
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-25 (study day 169.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-04-08 (study day 30.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild VENTRICULAR HYPERTROPHY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-25 (study day 169.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-04-11 (study day 33.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.